“Ongoing pressures in the labor and supply markets as a result of inflation continue to have a negative impact on operating income as do lower Medicare and Medicaid product underwriting margins,” UPMC said in the report.
The health system saw operating revenues of $7.1 billion in the three-month period ended March 31, up from $6.9 billion posted over the same period in 2023.
Net patient service revenues were $2.9 billion, up from $2.7 billion year over year. Insurance enrollment revenues were $3.7 billion, compared to $3.5 billion posted over the same period last year.
Total operating expenses were $7.2 billion, up from $6.8 billion over the same period in 2023.
Salaries, professional fees and benefit expenses were $2.5 billion, up from $2.4 billion last year. Supplies, purchased services and general expenses were $1.9 billion in the quarter, up from $1.8 billion in the same quarter in 2023. Insurance claims expenses were $2.6 billion, up from $2.4 billion last year.
After accounting for nonoperating items, such as investment returns, UPMC ended the quarter with a net loss of $24 million, down from a net gain of $191 million in the same quarter last year.
As of March 31, UPMC had more than $9.4 billion in cash and investments, $3.2 billion of which was held by its regulated health and captive insurance companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
